Sarcopenia and cardiovascular diseases
Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …
Exercise and nutrition impact on osteoporosis and sarcopenia—the incidence of osteosarcopenia: a narrative review
Osteoporosis and sarcopenia are diseases which affect the myoskeletal system and often
occur in older adults. They are characterized by low bone density and loss of muscle mass …
occur in older adults. They are characterized by low bone density and loss of muscle mass …
[HTML][HTML] Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in
individuals with obesity due to metabolic changes associated with a sedentary lifestyle …
individuals with obesity due to metabolic changes associated with a sedentary lifestyle …
[HTML][HTML] Advances in muscle health and nutrition: a toolkit for healthcare professionals
Low muscle mass and malnutrition are prevalent conditions among adults of all ages, with
any body weight or body mass index, and with acute or chronic conditions, including COVID …
any body weight or body mass index, and with acute or chronic conditions, including COVID …
Dietary management of adults with IBD—the emerging role of dietary therapy
Historically, dietitians played a minor part in the management of inflammatory bowel disease
(IBD), including Crohn's disease and ulcerative colitis. Patients were commonly referred for …
(IBD), including Crohn's disease and ulcerative colitis. Patients were commonly referred for …
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality
Y Akamatsu, T Kusakabe, H Arai… - Journal of cachexia …, 2022 - Wiley Online Library
Background Methods that facilitate muscle quality measurement may improve the diagnosis
of sarcopenia. Current research has focused on the phase angle (PhA) obtained through …
of sarcopenia. Current research has focused on the phase angle (PhA) obtained through …
Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies
Weight loss induced by glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and dual
glucagon‐like peptide‐1 receptor (GLP‐1R)/glucose‐dependent insulinotropic polypeptide …
glucagon‐like peptide‐1 receptor (GLP‐1R)/glucose‐dependent insulinotropic polypeptide …
Intermuscular adipose tissue in metabolic disease
Intermuscular adipose tissue (IMAT) is a distinct adipose depot described in early reports as
a 'fatty replacement'or 'muscle fat infiltration'that was linked to ageing and neuromuscular …
a 'fatty replacement'or 'muscle fat infiltration'that was linked to ageing and neuromuscular …
Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia
Myosteatosis, which is excessive fat infiltration in the skeletal muscle, is now considered a
distinct disease from sarcopenia. Advances in imaging technique have made muscle …
distinct disease from sarcopenia. Advances in imaging technique have made muscle …
Sarcopenia, osteoporosis and frailty
Muscles and bones are intricately connected tissues displaying marked co-variation during
development, growth, aging, and in many diseases. While the diagnosis and treatment of …
development, growth, aging, and in many diseases. While the diagnosis and treatment of …